Paper Details

Paper Title

Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer.

Paper Journal Title

J Clin Oncol

Paper Citation Count

120

Paper Publication Year

2010

Bio Mention

CRPC, PATIENTS, PC3, PC3 xenograft, PSA, bevacizumab, docetaxel, human, metastatic castration-resistant prostate cancer, mice, mouse, neutropenia, patient, patients, prednisone, prostate-specific antigen, thalidomide, tumor

Mesh Descriptor

Paper Details

Column Actions

Datasets